Floatz logo

CITALOPRAM

Metabolic Complication

Seoul National University HospitalSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Metabolic Complication cohort.

Asset / SponsorPhaseRating
Cipralex
Seoul National University Hospital
Phase 4BB
Sertraline
Seoul National University Hospital
Phase 4BB
Inositol
Milton S. Hershey Medical Center
Phase 2B

Same molecule, other indications

CITALOPRAM is also rated in:

Bipolar I DisorderDormant
BBB
Indicative ·
77 / 100
View asset →
bipolar disorderDormant
BBB
Indicative ·
74 / 100
View asset →
depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →